3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear

For the first time in eight years, a new Pfizer (NYSE: PFE) CEO took the stage at the J.P. Morgan Healthcare Conference. Albert Bourla took the reins from Ian Read only a few days ago. He and Mikael Dolsten, head of research and development for Pfizer, sat down to field questions at the conference on Monday.